Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
Planegg/Martinsried, November 11, 2024. Medigene AG ( Medigene or the "Company", FSE: MDG1, Prime Standard ) , an oncology platform company focused on the research and development of T cell receptor ( TCR ) -guided therapies for the treatment of cancer, presented latest updates on its End-to-End ...
| Ticker |
Sentiment |
Impact |
|
MDGEF
|
Somewhat Bullish
|
11 %
|
|
WXXWY
|
Neutral
|
4 %
|
|
BNTX
|
Neutral
|
4 %
|
